LEBRUN LABS™
Back to Resources
Conference Abstract

Summer School on Innovative Approaches in Science: An Improved Version of the OptiSafe™ Test with High Specificity

Summer School on Innovative Approaches in Science, 2020

Overview

Presented at an international forum dedicated to advancing nonanimal testing science, this abstract describes the development and optimization of the improved OptiSafe™ protocol from the perspective of innovative approach methodology (IAM). The work frames OptiSafe™ within the broader scientific movement toward mechanistically-grounded, human-relevant safety testing, explaining not just what the test does, but why its design choices produce more biologically accurate results than animal-based alternatives. The presentation highlights the in vitro approach for detecting GHS-classified ocular irritants and positions OptiSafe™ as a model for how nonanimal methods can be designed to outperform their animal-based predecessors.

Abstract

Development and optimization of nonanimal alternative test methods represents a central challenge in modern toxicology. The OptiSafe™ eye irritation test was developed as an in vitro approach for the detection of GHS-classified ocular irritants, using a macromolecular substrate to model the interaction between test substances and ocular tissue components. This abstract presents the development rationale, optimization strategy, and performance data for an improved version of the OptiSafe™ protocol with high specificity. The optimization approach incorporated biomimetic elements derived from the known chemistry of the ocular surface and tear film, including antioxidant components that neutralize reactive-but-nonirritating chemicals. The improved protocol was evaluated against a reference chemical set spanning GHS Category 1, Category 2, and No Category classifications. Results demonstrated high specificity, the ability to correctly classify nonirritants, while maintaining sensitivity for true ocular irritants and corrosives. The work illustrates how mechanistic understanding of ocular biology can be translated into improved in vitro test design.

Relevance to Lebrun Labs Services

The mechanistic design principles described in this abstract are what distinguish OptiSafe™ from simpler protein-denaturation assays. By building the biology of the eye into the test design, rather than simply measuring nonspecific reactivity, Lebrun Labs has created a test that produces results that are more meaningful for real-world product safety. For clients in the cosmetics, personal care, and specialty chemical industries who need eye irritation data that accurately reflects human ocular hazard, this mechanistic foundation is a key reason to choose OptiSafe™ over less sophisticated alternatives. Our team can explain how the test's design applies to your specific formulation and what the results will mean for your regulatory submissions.

Research reported in this publication was supported by the National Institute of Environmental Health Sciences of the National Institutes of Health under Award Number SB1ES025501. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.